Zollinger-Ellison syndrome: Difference between revisions
No edit summary |
|||
| Line 35: | Line 35: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:GI]] | |||
Revision as of 21:04, 31 August 2022
Background
- Also known as "S-E syndrome"
- gastric neuroendocrine malignancy results in hypersecretion of hydrochloric acid by parietal cells
- Associated with peptic ulcers and diarrhea
- 60% malignant, only 20% resectable; 25% of gastrinoma patients have multiple endocrine neoplasia type I; >80% of gastrinomas found in gastrinoma triangle.
Clinical Features
- Hematemesis
- Chronic diarrhea
- Postprandial abdominal pain
- Nausea
- Wheezes on auscultation
- Evidence of malnourishment and decreased oral intake